NYSE:FMS - Fresenius Medical Care AG & Co. Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $51.82 +0.50 (+0.97 %) (As of 09/25/2018 04:00 PM ET)Previous Close$51.32Today's Range$51.79 - $52.0952-Week Range$47.19 - $57.94Volume120,600 shsAverage Volume139,199 shsMarket Capitalization$31.32 billionP/E Ratio23.22Dividend Yield0.83%Beta0.79 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany. Receive FMS News and Ratings via Email Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical SymbolNYSE:FMS CUSIPN/A Webwww.freseniusmedicalcare.com Phone49-6172-6090 Debt Debt-to-Equity Ratio0.46 Current Ratio1.37 Quick Ratio1.11 Price-To-Earnings Trailing P/E Ratio23.22 Forward P/E Ratio21.77 P/E Growth3.03 Sales & Book Value Annual Sales$20.09 billion Price / Sales1.58 Cash Flow$3.6263 per share Price / Cash14.29 Book Value$19.97 per share Price / Book2.59 Profitability EPS (Most Recent Fiscal Year)$2.21 Net Income$1.45 billion Net Margins11.65% Return on Equity10.78% Return on Assets4.91% Miscellaneous Employees114,000 Outstanding Shares612,900,000Market Cap$31.32 billion Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions What is Fresenius Medical Care AG & Co.'s stock symbol? Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS." How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co. announced an annual dividend on Thursday, May 10th. Stockholders of record on Tuesday, May 22nd will be paid a dividend of $0.436 per share on Monday, June 4th. This represents a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, May 21st. View Fresenius Medical Care AG & Co.'s Dividend History. How were Fresenius Medical Care AG & Co.'s earnings last quarter? Fresenius Medical Care AG & Co. (NYSE:FMS) announced its earnings results on Tuesday, July, 31st. The company reported $0.54 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.60 by $0.06. The company had revenue of $4.21 billion for the quarter, compared to analysts' expectations of $4.28 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.78% and a net margin of 11.65%. The company's revenue was down 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.89 EPS. View Fresenius Medical Care AG & Co.'s Earnings History. When is Fresenius Medical Care AG & Co.'s next earnings date? Fresenius Medical Care AG & Co. is scheduled to release their next quarterly earnings announcement on Tuesday, October, 30th 2018. View Earnings Estimates for Fresenius Medical Care AG & Co.. What price target have analysts set for FMS? 10 brokers have issued 12 month price objectives for Fresenius Medical Care AG & Co.'s stock. Their predictions range from $62.00 to $62.00. On average, they expect Fresenius Medical Care AG & Co.'s share price to reach $62.00 in the next twelve months. This suggests a possible upside of 19.6% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co.. What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co.? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co.. Who are some of Fresenius Medical Care AG & Co.'s key competitors? Some companies that are related to Fresenius Medical Care AG & Co. include Davita (DVA), Tivity Health (TVTY), American Renal Associates (ARA), Catasys (CATS), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), BioRestorative Therapies (BRTX), MYnd Analytics (MYND), Hooper Holmes (HPHW) and American Caresource (GNOW). Who are Fresenius Medical Care AG & Co.'s key executives? Fresenius Medical Care AG & Co.'s management team includes the folowing people: Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56) Who are Fresenius Medical Care AG & Co.'s major shareholders? Fresenius Medical Care AG & Co.'s stock is owned by a number of of institutional and retail investors. Top institutional investors include Morgan Stanley (0.20%), Bank of America Corp DE (0.14%), Northern Trust Corp (0.14%), FMR LLC (0.10%), US Bancorp DE (0.05%) and Aperio Group LLC (0.04%). Which major investors are selling Fresenius Medical Care AG & Co. stock? FMS stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Millennium Management LLC, Citadel Advisors LLC, First Trust Advisors LP, Sivik Global Healthcare LLC, Bank of America Corp DE, BB&T Corp and US Bancorp DE. Which major investors are buying Fresenius Medical Care AG & Co. stock? FMS stock was bought by a variety of institutional investors in the last quarter, including Ferguson Wellman Capital Management Inc., Bank of Montreal Can, Russell Investments Group Ltd., Northern Trust Corp, Aperio Group LLC, Confluence Investment Management LLC, Cornerstone Wealth Management LLC and Cambiar Investors LLC. How do I buy shares of Fresenius Medical Care AG & Co.? Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Fresenius Medical Care AG & Co.'s stock price today? One share of FMS stock can currently be purchased for approximately $51.82. How big of a company is Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co. has a market capitalization of $31.32 billion and generates $20.09 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $2.21 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 114,000 workers across the globe. What is Fresenius Medical Care AG & Co.'s official website? The official website for Fresenius Medical Care AG & Co. is http://www.freseniusmedicalcare.com. How can I contact Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-6090 or via email at [email protected] MarketBeat Community Rating for Fresenius Medical Care AG & Co. (NYSE FMS)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 247 (Vote Outperform)Underperform Votes: 363 (Vote Underperform)Total Votes: 610MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/25/2018 by MarketBeat.com StaffFeatured Article: How are the companies in the S&P 500 selected?